https://api-data.net/unmet-opportunities-analyzing-the-fda-list-of-drugs-without-approved-generics/ 2025-08-23T17:52:41+00:00 https://api-data.net/gaming-generic-drug-approvals-legitimate-loopholes-and-illicit-tactics/ 2025-08-23T16:51:36+00:00 https://api-data.net/wp-content/uploads/2025/08/1744533561184.jpg https://api-data.net/when-trust-fails-in-pharma-how-data-corruption-in-api-manufacturing-will-trigger-a-billion-dollar-investor-exodus-in-2025-2026/ 2025-08-23T17:52:00+00:00 https://api-data.net/dirty-pills-and-empty-shelves-how-outsourcing-broke-americas-drug-supply/ 2025-08-23T18:05:01+00:00 https://api-data.net/wp-content/uploads/2025/08/1752320097729.png https://api-data.net/wp-content/uploads/2025/08/1752320460527.png https://api-data.net/britains-big-pharma-showdown-nhs-drug-levy-sparks-11-billion-rd-exodus-threat/ 2025-08-23T18:13:37+00:00 https://api-data.net/cracking-down-on-orphan-drug-abuse-the-orphan-cures-act-and-its-impact/ 2025-08-23T18:22:36+00:00 https://api-data.net/wp-content/uploads/2025/08/1748290004131.jpg https://api-data.net/digital-twins-the-future-of-obesity-treatment/ 2025-08-30T12:39:06+00:00 https://api-data.net/navigating-online-pharmacy-risks/ 2025-08-30T11:15:07+00:00 https://api-data.net/disaster-ready-are-we-prepared/ 2025-08-30T11:12:56+00:00 https://api-data.net/fdas-bold-move-pfizers-eua-revoked/ 2025-08-30T16:28:43+00:00 https://api-data.net/turning-cancer-on-its-head/ 2025-08-30T12:44:37+00:00 https://api-data.net/beone-advances-sonrotoclax-a-potential-breakthrough-in-rare-b-cell-lymphoma-treatment/ 2025-08-31T09:44:53+00:00 https://api-data.net/leadership-changes-at-novo-nordisk-and-rocket-pharma/ 2025-08-31T19:21:46+00:00 https://api-data.net/abbvies-gilgamesh-acquisition-a-strategic-shift-to-single-asset-focus/ 2025-08-31T19:17:48+00:00 https://api-data.net/outlooks-wet-amd-candidate-faces-second-fda-rejection/ 2025-08-31T07:45:09+00:00 https://api-data.net/a-new-dawn-for-gca-treatment/ 2025-08-31T07:26:58+00:00 https://api-data.net/esperions-bempedoic-acid-receives-level-1a-recommendation-in-updated-esc-eas-guidelines-for-management-of-dyslipidaemias/ 2025-09-02T19:45:42+00:00 https://api-data.net/zydus-therapeutics-secures-phase-2b-3-victory-in-liver-disease-a-strategic-move-against-gilead-and-ipsen/ 2025-08-31T08:23:18+00:00 https://api-data.net/physician-enthusiasm-for-novos-wegovy-suggests-swift-uptake-in-rezdiffra-dominated-mash-market/ 2025-08-31T08:43:43+00:00 https://api-data.net/eisai-secures-fda-approval-for-leqembi-autoinjector-enabling-at-home-maintenance-dosing/ 2025-09-02T19:43:09+00:00 https://api-data.net/__trashed-75/ 2025-09-05T18:07:58+00:00 https://api-data.net/zenas-biopharma-royalty-pharma-enter-obexelimab-funding-agreement-for-up-to-300-million/ 2025-09-02T15:05:25+00:00 https://api-data.net/fda-grants-rmat-designation-to-etx101-for-dravet-syndrome/ 2025-09-02T14:38:12+00:00 https://api-data.net/step-pharma-initiates-phase-1b-trial-of-dencatistat-for-essential-thrombocythaemia/ 2025-09-04T02:46:26+00:00 https://api-data.net/omass-therapeutics-enters-exclusive-collaboration-license-agreement-with-genentech/ 2025-09-04T02:49:49+00:00 https://api-data.net/tyvaso-achieves-phase-3-success-in-ipf-trial/ 2025-09-06T07:05:58+00:00 https://api-data.net/ionis-reports-positive-phase-3-results-for-tryngolza/ 2025-09-05T18:03:17+00:00 https://api-data.net/capvest-partners-acquires-stada-abandoning-ipo-strategy/ 2025-09-03T08:55:33+00:00 https://api-data.net/novos-wegovy-outperforms-lillys-zepbound-in-cardiovascular-risk-reduction/ 2025-09-03T08:57:55+00:00 https://api-data.net/prasad-proposes-new-vaccine-approval-strategies/ 2025-09-05T18:40:54+00:00 https://api-data.net/fdas-drug-safety-oversight-board-established/ 2025-09-05T18:43:37+00:00 https://api-data.net/mytos-expands-cell-therapy-manufacturing-partnerships/ 2025-09-06T07:07:27+00:00 https://api-data.net/fda-enhances-generic-drug-competition/ 2025-09-06T09:45:50+00:00 https://api-data.net/endpoints-11-winners-in-2025-biotech-downturn/ 2025-09-06T09:50:05+00:00 https://api-data.net/evaluating-promising-biotech-startups/ 2025-09-07T08:06:05+00:00 https://api-data.net/wave-life-sciences-reports-rna-therapy-results/ 2025-09-07T08:09:50+00:00 https://api-data.net/treeline-biosciences-secures-200m-funding-boost/ 2025-09-06T07:13:42+00:00 https://api-data.net/artelo-biosciences-reports-promising-phase-2-cares-results/ 2025-09-06T07:13:09+00:00 https://api-data.net/paul-offit-exits-key-fda-vaccine-panel/ 2025-09-06T09:48:14+00:00 https://api-data.net/uk-pharma-trade-group-calls-for-government-evaluation-overhaul/ 2025-09-07T08:08:38+00:00 https://api-data.net/phrma-launches-campaign-on-340b-mark-ups/ 2025-09-06T07:08:12+00:00 https://api-data.net/ori-biotech-secures-fda-advanced-manufacturing-designation-for-iro-platform/ 2025-09-07T08:01:18+00:00 https://api-data.net/mindmed-reveals-promising-phase-2b-lsd-data-for-generalized-anxiety-disorder/ 2025-09-08T16:01:15+00:00 https://api-data.net/astrazeneca-ends-manufacturing-license-at-indian-plant-as-it-exits-the-site/ 2025-09-08T16:53:48+00:00 https://api-data.net/jj-bristol-myers-lose-appeals-cases-challenging-medicare-price-negotiation/ 2025-09-08T17:34:01+00:00 https://api-data.net/rfk-jr-faces-bipartisan-backlash-over-vaccine-policy-decisions/ 2025-09-08T18:08:12+00:00 https://api-data.net/fda-publishes-drug-rejection-letters-for-ongoing-applications-for-the-first-time/ 2025-09-08T18:00:37+00:00 https://api-data.net/bavarian-nordics-vimkunya-makes-uk-debut-amid-ixchiq-suspension/ 2025-09-08T17:00:38+00:00 https://api-data.net/rfk-jr-blasts-pharma-industry-touts-mrna-misinformation-in-heated-senate-hearing/ 2025-09-08T15:14:06+00:00 https://api-data.net/hengrui-pharmaceuticals-enters-us-market-with-cytokinetics-collaboration-in-cardiology/ 2025-09-08T18:42:54+00:00 https://api-data.net/gilead-sciences-advances-hiv-prevention-with-new-us-partnership/ 2025-09-08T18:05:40+00:00 https://api-data.net/ema-warns-of-rise-in-illegal-weight-loss-drugs-marketed-online/ 2025-09-08T20:03:13+00:00 https://api-data.net/mrm-health-secures-64m-to-advance-microbiome-based-biotherapeutics/ 2025-09-08T21:01:12+00:00 https://api-data.net/prac-initiates-review-of-levamisole-for-leukoencephalopathy-risk/ 2025-09-08T22:03:05+00:00 https://api-data.net/abbvies-skyrizi-and-rinvoq-maintain-dominance-in-august-tv-drug-ad-spending/ 2025-09-08T16:33:28+00:00 https://api-data.net/biontech-and-dualitybios-adc-achieves-success-in-late-stage-breast-cancer-trial-in-china/ 2025-09-09T03:06:10+00:00 https://api-data.net/rfk-jr-defends-vaccine-policies-in-heated-senate-hearing/ 2025-09-08T23:04:25+00:00 https://api-data.net/multiply-labs-biomanufacturing-robot-to-slash-cell-therapy-costs/ 2025-09-09T04:00:29+00:00 https://api-data.net/orexos-amorphox-technology-may-pave-the-way-for-intranasal-glp-1-medication/ 2025-09-09T07:01:08+00:00 https://api-data.net/thermo-fisher-scientific-launches-ultracomp-ebeads-to-enhance-flow-cytometry-precision/ 2025-09-09T08:00:10+00:00 https://api-data.net/a-rare-kind-of-leadership-30-years-in-the-making/ 2025-09-09T15:24:17+00:00 https://api-data.net/japan-made-generic-drugs-exempt-from-trumps-reciprocal-tariff/ 2025-09-09T12:05:19+00:00 https://api-data.net/target-discovery-platform-multi-omics-siteseeker-technology-the-future-of-targeted-protein-degradation/ 2025-09-09T11:00:50+00:00 https://api-data.net/rapafusyn-pharmaceuticals-secures-44m-in-series-a-funding/ 2025-09-09T14:00:20+00:00 https://api-data.net/navigating-the-lipid-landscape-overcoming-challenges-in-lipid-sourcing-for-lnps/ 2025-09-09T15:00:28+00:00 https://api-data.net/gsk-expands-mrna-patent-litigation-to-include-modernas-next-generation-covid-shot/ 2025-09-09T00:02:25+00:00 https://api-data.net/perrigo-moves-to-replace-striking-workers-at-nyc-plant-amid-strategy-shift/ 2025-09-09T15:22:33+00:00 https://api-data.net/europe-issues-alert-on-surge-of-counterfeit-novo-and-lilly-weight-loss-drugs/ 2025-09-09T01:00:41+00:00 https://api-data.net/point-of-care-pharma-marketing-spending-passes-1b-milestone/ 2025-09-09T06:00:08+00:00 https://api-data.net/astellas-launches-global-initiative-to-combat-menopause-stigma-in-the-workplace/ 2025-09-09T02:30:58+00:00 https://api-data.net/cystic-fibrosis-market-forecast-to-reach-16-0bn-by-2034-in-the-7mm/ 2025-09-09T10:03:12+00:00 https://api-data.net/maraganore-and-meanwell-collaborate-as-fda-issues-crls/ 2025-09-09T16:01:21+00:00 https://api-data.net/wclc25-summit-reports-full-phase-3-data-from-first-group-of-western-lung-cancer-patients/ 2025-09-09T17:02:19+00:00 https://api-data.net/summits-global-pd-1xvegf-data-challenge-regional-consistency-claims-but-show-new-promising-survival-trend/ 2025-09-09T18:01:57+00:00 https://api-data.net/servier-acquires-medicxi-startups-fragile-x-candidate-for-up-to-450m/ 2025-09-09T21:09:33+00:00 https://api-data.net/mitochondrial-startup-secures-50m-to-advance-lead-drug-for-als-and-parkinsons-disease/ 2025-09-09T23:00:37+00:00 https://api-data.net/takedas-phase-3-narcolepsy-trials-position-it-as-potential-first-mover-in-multibillion-dollar-market/ 2025-09-09T22:00:41+00:00 https://api-data.net/astrazenecas-tagrisso-and-chemotherapy-combination-reduces-mortality-risk-by-23-in-advanced-egfr-mutant-lung-cancer/ 2025-09-10T01:18:59+00:00 https://api-data.net/rapport-reports-promising-open-label-study-data-for-epilepsy-pill-heads-to-phase-3/ 2025-09-10T06:00:41+00:00 https://api-data.net/novonesis-and-novo-nordisk-collaborate-on-gut-microbiome-solutions-for-metabolic-health/ 2025-09-10T07:01:09+00:00 https://api-data.net/lexicon-pharmaceuticals-submits-additional-data-to-fda-for-zynquista-in-type-1-diabetes/ 2025-09-10T08:00:11+00:00 https://api-data.net/alzpaths-ptau217-antibody-set-to-revolutionize-alzheimers-disease-diagnostics/ 2025-09-10T09:00:13+00:00 https://api-data.net/trump-carves-out-generics-from-15-tariffs-in-us-japan-trade-deal/ 2025-09-10T05:59:58+00:00 https://api-data.net/eli-lillys-jaypirca-achieves-primary-endpoint-in-phase-3-trial-moving-toward-first-line-cll-use/ 2025-09-10T05:01:55+00:00 https://api-data.net/md-anderson-and-phoenix-to-advance-cell-and-gene-therapy-tech/ 2025-09-10T02:00:51+00:00 https://api-data.net/hengrui-pharma-signs-exclusive-license-agreement-with-braveheart-bio-for-hrs-1893/ 2025-09-10T00:01:21+00:00